A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Within the European Union, biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Biosimilar industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market Segment by Product Application
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Biosimilar consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Biosimilar market by identifying its various subsegments.
3.Focuses on the key global Biosimilar manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Biosimilar submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Biosimilar Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Biosimilar Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Biosimilar Segment by Type
2.1.1 Monoclonal Antibodies
2.1.2 Interferon
2.1.3 Erythropoietin
2.1.4 Insulin
2.1.5 Vaccines
2.1.6 Other
2.2 Market Analysis by Application
2.2.1 Tumor
2.2.2 Diabetes
2.2.3 Cardiovascular
2.2.4 Hemophilia
2.2.5 Other
2.3 Global Biosimilar Market Comparison by Regions (2017-2027)
2.3.1 Global Biosimilar Market Size (2017-2027)
2.3.2 North America Biosimilar Status and Prospect (2017-2027)
2.3.3 Europe Biosimilar Status and Prospect (2017-2027)
2.3.4 Asia-pacific Biosimilar Status and Prospect (2017-2027)
2.3.5 South America Biosimilar Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Biosimilar Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Biosimilar Industry Impact
2.5.1 Biosimilar Business Impact Assessment - Covid-19
2.5.2 Market Trends and Biosimilar Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Biosimilar Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Biosimilar Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Biosimilar Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Biosimilar Manufacturer Market Share
3.5 Top 10 Biosimilar Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Biosimilar Market
3.7 Key Manufacturers Biosimilar Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Biosimilar Industry Key Manufacturers
4.1 Roche
4.1.1 Company Details
4.1.2 Roche Biosimilar Product Introduction, Application and Specification
4.1.3 Roche Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Roche News
4.2 Eli Lilly
4.2.1 Company Details
4.2.2 Eli Lilly Biosimilar Product Introduction, Application and Specification
4.2.3 Eli Lilly Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Eli Lilly News
4.3 Sanofi-Aventis
4.3.1 Company Details
4.3.2 Sanofi-Aventis Biosimilar Product Introduction, Application and Specification
4.3.3 Sanofi-Aventis Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sanofi-Aventis News
4.4 Amgen
4.4.1 Company Details
4.4.2 Amgen Biosimilar Product Introduction, Application and Specification
4.4.3 Amgen Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Amgen News
4.5 Novo Nordisk
4.5.1 Company Details
4.5.2 Novo Nordisk Biosimilar Product Introduction, Application and Specification
4.5.3 Novo Nordisk Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Novo Nordisk News
4.6 AbbVie
4.6.1 Company Details
4.6.2 AbbVie Biosimilar Product Introduction, Application and Specification
4.6.3 AbbVie Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AbbVie News
4.7 Merck
4.7.1 Company Details
4.7.2 Merck Biosimilar Product Introduction, Application and Specification
4.7.3 Merck Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Merck News
4.8 Pfizer
4.8.1 Company Details
4.8.2 Pfizer Biosimilar Product Introduction, Application and Specification
4.8.3 Pfizer Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Pfizer News
4.9 Johnson & Johnson
4.9.1 Company Details
4.9.2 Johnson & Johnson Biosimilar Product Introduction, Application and Specification
4.9.3 Johnson & Johnson Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Johnson & Johnson News
4.10 Novartis
4.10.1 Company Details
4.10.2 Novartis Biosimilar Product Introduction, Application and Specification
4.10.3 Novartis Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Novartis News
4.11 Gelgen
4.11.1 Company Details
4.11.2 Gelgen Biosimilar Product Introduction, Application and Specification
4.11.3 Gelgen Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Gelgen News
4.12 Ganlee
4.12.1 Company Details
4.12.2 Ganlee Biosimilar Product Introduction, Application and Specification
4.12.3 Ganlee Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Ganlee News
4.13 3sbio
4.13.1 Company Details
4.13.2 3sbio Biosimilar Product Introduction, Application and Specification
4.13.3 3sbio Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 3sbio News
4.14 Innovent
4.14.1 Company Details
4.14.2 Innovent Biosimilar Product Introduction, Application and Specification
4.14.3 Innovent Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Innovent News
4.15 Biotech
4.15.1 Company Details
4.15.2 Biotech Biosimilar Product Introduction, Application and Specification
4.15.3 Biotech Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Biotech News
4.16 Changchun High Tech
4.16.1 Company Details
4.16.2 Changchun High Tech Biosimilar Product Introduction, Application and Specification
4.16.3 Changchun High Tech Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Changchun High Tech News
4.17 Dong Bao
4.17.1 Company Details
4.17.2 Dong Bao Biosimilar Product Introduction, Application and Specification
4.17.3 Dong Bao Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Dong Bao News
4.18 CP Guojian
4.18.1 Company Details
4.18.2 CP Guojian Biosimilar Product Introduction, Application and Specification
4.18.3 CP Guojian Biosimilar Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.18.4 Main Business Overview
4.18.5 CP Guojian News
5 Global Biosimilar Sales Categorized by Regions
5.1 Global Biosimilar Revenue, Sales and Market Share by Regions
5.1.1 Global Biosimilar Sales and Market Share by Regions (2017-2022)
5.1.2 Global Biosimilar Revenue and Market Share by Regions (2017-2022)
5.2 North America Biosimilar Sales and Growth Rate (2017-2022)
5.3 Europe Biosimilar Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Biosimilar Sales and Growth Rate (2017-2022)
5.5 South America Biosimilar Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Biosimilar Sales and Growth Rate (2017-2022)
6 North America Biosimilar Market Size Categorized by Countries
6.1 North America Biosimilar Sales, Revenue and Market Share by Countries
6.1.1 North America Biosimilar Sales (Volume) by Countries (2017-2022)
6.1.2 North America Biosimilar Revenue by Countries (2017-2022)
6.1.3 United States Biosimilar Sales and Growth Rate (2017-2022)
6.1.4 Canada Biosimilar Sales and Growth Rate (2017-2022)
6.1.5 Mexico Biosimilar Sales and Growth Rate (2017-2022)
6.2 North America Biosimilar Revenue (Value) by Manufacturers
6.3 North America Biosimilar Sales and Market Share by Type (2017-2022)
6.4 North America Biosimilar Sales Market Share by Application (2017-2022)
7 Europe Biosimilar Market Size Categorized by Countries
7.1 Europe Biosimilar Sales, Revenue and Market Share by Countries
7.1.1 Europe Biosimilar Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Biosimilar Revenue by Countries (2017-2022)
7.1.3 Germany Biosimilar Sales and Growth Rate (2017-2022)
7.1.4 UK Biosimilar Sales and Growth Rate (2017-2022)
7.1.5 France Biosimilar Sales and Growth Rate (2017-2022)
7.1.6 Russia Biosimilar Sales and Growth Rate (2017-2022)
7.1.7 Italy Biosimilar Sales and Growth Rate (2017-2022)
7.1.8 Spain Biosimilar Sales and Growth Rate (2017-2022)
7.2 Europe Biosimilar Revenue (Value) by Manufacturers
7.3 Europe Biosimilar Sales and Market Share by Type (2017-2022)
7.4 Europe Biosimilar Sales Market Share by Application (2017-2022)
8 Asia-Pacific Biosimilar Market Size Categorized by Countries
8.1 Asia-pacific Biosimilar Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Biosimilar Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Biosimilar Revenue by Countries (2017-2022)
8.1.3 China Biosimilar Sales and Growth Rate (2017-2022)
8.1.4 South Korea Biosimilar Sales and Growth Rate (2017-2022)
8.1.5 Japan Biosimilar Sales and Growth Rate (2017-2022)
8.1.6 Australia Biosimilar Sales and Growth Rate (2017-2022)
8.1.7 India Biosimilar Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Biosimilar Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Biosimilar Revenue (Value) by Manufacturers
8.3 Asia-pacific Biosimilar Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Biosimilar Sales Market Share by Application (2017-2022)
9 South America Biosimilar Market Size Categorized by Countries
9.1 South America Biosimilar Sales, Revenue and Market Share by Countries
9.1.1 South America Biosimilar Sales (Volume) by Countries (2017-2022)
9.1.2 South America Biosimilar Revenue by Countries (2017-2022)
9.1.3 Brazil Biosimilar Sales and Growth Rate (2017-2022)
9.2 South America Biosimilar Sales and Market Share by Type (2017-2022)
9.3 South America Biosimilar Sales Market Share by Application (2017-2022)
10 Middle East and Africa Biosimilar Market Size Categorized by Countries
10.1 Middle East and Africa Biosimilar Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Biosimilar Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Biosimilar Revenue by Countries (2017-2022)
10.1.3 GCC Countries Biosimilar Sales and Growth Rate (2017-2022)
10.1.4 Turkey Biosimilar Sales and Growth Rate (2017-2022)
10.1.5 Egypt Biosimilar Sales and Growth Rate (2017-2022)
10.1.6 South America Biosimilar Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Biosimilar Sales and Market Share by Type
10.3 Middle East and Africa Biosimilar Sales Market Share by Application (2017-2022)
11 Global Biosimilar Market Segment by Type
11.1 Global Biosimilar Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Biosimilar Sales and Market Share by Type (2017-2022)
11.1.2 Global Biosimilar Revenue and Market Share by Type (2017-2022)
11.2 Monoclonal Antibodies Sales Growth Rate and Price
11.2.1 Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
11.2.2 Global Monoclonal Antibodies Price (2017-2022)
11.3 Interferon Sales Growth Rate and Price
11.3.1 Global Interferon Sales Growth Rate (2017-2022)
11.3.2 Global Interferon Price (2017-2022)
11.4 Erythropoietin Sales Growth Rate and Price
11.4.1 Global Erythropoietin Sales Growth Rate (2017-2022)
11.4.2 Global Erythropoietin Price (2017-2022)
11.5.1 Global Insulin Sales Growth Rate (2017-2022)
11.5.2 Global Insulin Price (2017-2022)
11.6 Vaccines Sales Growth Rate and Price
11.6.1 Global Vaccines Sales Growth Rate (2017-2022)
11.6.2 Global Vaccines Price (2017-2022)
11.7 Other Sales Growth Rate and Price
11.7.1 Global Other Sales Growth Rate (2017-2022)
11.7.2 Global Other Price (2017-2022)
12 Global Biosimilar Market Segment by Application
12.1 Global Biosimilar Sales Market Share by Application (2017-2022)
12.2 Tumor Sales Growth Rate (2017-2022)
12.3 Diabetes Sales Growth Rate (2017-2022)
12.4 Cardiovascular Sales Growth Rate (2017-2022)
12.5 Hemophilia Sales Growth Rate (2017-2022)
13 Global Biosimilar Market Forecast
13.1 Global Biosimilar Revenue, Sales and Growth Rate (2022-2027)
13.2 Biosimilar Market Forecast by Regions (2022-2027)
13.2.1 North America Biosimilar Market Forecast (2022-2027)
13.2.2 Europe Biosimilar Market Forecast (2022-2027)
13.2.3 Asia-Pacific Biosimilar Market Forecast (2022-2027)
13.2.4 South America Biosimilar Market Forecast (2022-2027)
13.2.5 Middle East & Africa Biosimilar Market Forecast (2022-2027)
13.3 Biosimilar Market Forecast by Type (2022-2027)
13.3.1 Global Biosimilar Sales Forecast by Type (2022-2027)
13.3.2 Global Biosimilar Market Share Forecast by Type (2022-2027)
13.4 Biosimilar Market Forecast by Application (2022-2027)
13.4.1 Global Biosimilar Sales Forecast by Application (2022-2027)
13.4.2 Global Biosimilar Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Biosimilar Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Biosimilar Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Biosimilar
Figure Market Concentration Ratio and Market Maturity Analysis of Biosimilar
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Biosimilar Market Size by Type
Figure Global Market Share of Biosimilar by Type in 2021
Figure Monoclonal Antibodies Picture
Figure Interferon Picture
Figure Erythropoietin Picture
Figure Insulin Picture
Figure Vaccines Picture
Figure Other Picture
Table Global Biosimilar Market Size (Volume) by Application
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Table Global Biosimilar Comparison by Regions (M USD) 2017-2027
Figure Global Biosimilar Market Size (Million US$) (2017-2027)
Figure North America Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Biosimilar Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Biosimilar Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Biosimilar Sales by Manufacturer (2017-2022)
Figure Global Biosimilar Sales Market Share by Manufacturer in 2021
Table Global Biosimilar Revenue by Manufacturer (2017-2022)
Figure Global Biosimilar Revenue Market Share by Manufacturer in 2021
Table Global Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Biosimilar Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Biosimilar Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Biosimilar Market
Table Key Manufacturers Biosimilar Product Type
Table Mergers & Acquisitions Planning
Table Roche Company Profile
Table Biosimilar Product Introduction, Application and Specification of Roche
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Roche 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Eli Lilly Company Profile
Table Biosimilar Product Introduction, Application and Specification of Eli Lilly
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Eli Lilly 2017-2022
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Sanofi-Aventis Company Profile
Table Biosimilar Product Introduction, Application and Specification of Sanofi-Aventis
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi-Aventis 2017-2022
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Amgen Company Profile
Table Biosimilar Product Introduction, Application and Specification of Amgen
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amgen 2017-2022
Table Amgen Main Business
Table Amgen Recent Development
Table Novo Nordisk Company Profile
Table Biosimilar Product Introduction, Application and Specification of Novo Nordisk
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novo Nordisk 2017-2022
Table Novo Nordisk Main Business
Table Novo Nordisk Recent Development
Table AbbVie Company Profile
Table Biosimilar Product Introduction, Application and Specification of AbbVie
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AbbVie 2017-2022
Table AbbVie Main Business
Table AbbVie Recent Development
Table Merck Company Profile
Table Biosimilar Product Introduction, Application and Specification of Merck
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2017-2022
Table Merck Main Business
Table Merck Recent Development
Table Pfizer Company Profile
Table Biosimilar Product Introduction, Application and Specification of Pfizer
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Johnson & Johnson Company Profile
Table Biosimilar Product Introduction, Application and Specification of Johnson & Johnson
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis Company Profile
Table Biosimilar Product Introduction, Application and Specification of Novartis
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Gelgen Company Profile
Table Biosimilar Product Introduction, Application and Specification of Gelgen
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen 2017-2022
Table Gelgen Main Business
Table Gelgen Recent Development
Table Ganlee Company Profile
Table Biosimilar Product Introduction, Application and Specification of Ganlee
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Ganlee 2017-2022
Table Ganlee Main Business
Table Ganlee Recent Development
Table 3sbio Company Profile
Table Biosimilar Product Introduction, Application and Specification of 3sbio
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2017-2022
Table 3sbio Main Business
Table 3sbio Recent Development
Table Innovent Company Profile
Table Biosimilar Product Introduction, Application and Specification of Innovent
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Innovent 2017-2022
Table Innovent Main Business
Table Innovent Recent Development
Table Biotech Company Profile
Table Biosimilar Product Introduction, Application and Specification of Biotech
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Biotech 2017-2022
Table Biotech Main Business
Table Biotech Recent Development
Table Changchun High Tech Company Profile
Table Biosimilar Product Introduction, Application and Specification of Changchun High Tech
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2017-2022
Table Changchun High Tech Main Business
Table Changchun High Tech Recent Development
Table Dong Bao Company Profile
Table Biosimilar Product Introduction, Application and Specification of Dong Bao
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dong Bao 2017-2022
Table Dong Bao Main Business
Table Dong Bao Recent Development
Table CP Guojian Company Profile
Table Biosimilar Product Introduction, Application and Specification of CP Guojian
Table Biosimilar Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian 2017-2022
Table CP Guojian Main Business
Table CP Guojian Recent Development
Figure Global Biosimilar Sales and Growth Rate (2017-2022)
Figure Global Biosimilar Revenue and Growth Rate (2017-2022)
Table Global Biosimilar Sales by Regions (2017-2022)
Figure Global Biosimilar Sales Market Share by Regions in 2021
Table Global Biosimilar Revenue by Regions (2017-2022)
Figure Global Biosimilar Revenue Market Share by Regions in 2021
Figure North America Biosimilar Sales and Growth Rate (2017-2022)
Figure Europe Biosimilar Sales and Growth Rate (2017-2022)
Figure Asia-pacific Biosimilar Sales and Growth Rate (2017-2022)
Figure South America Biosimilar Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Biosimilar Sales and Growth Rate (2017-2022)
Figure North America Biosimilar Revenue and Growth Rate (2017-2022)
Table North America Biosimilar Sales (Volume) by Countries (2017-2022)
Table North America Biosimilar Sales Market Share by Countries (2017-2022)
Figure North America Biosimilar Sales Market Share by Countries in 2021
Table North America Biosimilar Revenue by Countries (2017-2022)
Table North America Biosimilar Revenue Market Share by Countries (2017-2022)
Figure North America Biosimilar Revenue Market Share by Countries in 2021
Figure United States Biosimilar Sales and Growth Rate (2017-2022)
Figure Canada Biosimilar Sales and Growth Rate (2017-2022)
Figure Mexico Biosimilar Sales and Growth Rate (2017-2022)
Table North America Biosimilar Revenue by Manufacturer (2021)
Figure North America Biosimilar Revenue Market Share by Manufacturer in 2021
Table North America Biosimilar Sales by Type (2017-2022)
Table North America Biosimilar Sales Share by Type (2017-2022)
Table North America Biosimilar Sales by Application (2017-2022)
Table North America Biosimilar Sales Share by Application (2017-2022)
Figure Europe Biosimilar Revenue and Growth Rate (2017-2022)
Table Europe Biosimilar Sales (Volume) by Countries (2017-2022)
Table Europe Biosimilar Sales Market Share by Countries (2017-2022)
Figure Europe Biosimilar Sales Market Share by Countries in 2021
Table Europe Biosimilar Revenue by Countries (2017-2022)
Table Europe Biosimilar Revenue Market Share by Countries (2017-2022)
Figure Europe Biosimilar Revenue Market Share by Countries in 2021
Figure Germany Biosimilar Sales and Growth Rate (2017-2022)
Figure UK Biosimilar Sales and Growth Rate (2017-2022)
Figure France Biosimilar Sales and Growth Rate (2017-2022)
Figure Russia Biosimilar Sales and Growth Rate (2017-2022)
Figure Italy Biosimilar Sales and Growth Rate (2017-2022)
Figure Spain Biosimilar Sales and Growth Rate (2017-2022)
Table Europe Biosimilar Revenue by Manufacturer (2021)
Figure Europe Biosimilar Revenue Market Share by Manufacturer in 2021
Table Europe Biosimilar Sales by Type (2017-2022)
Table Europe Biosimilar Sales Share by Type (2017-2022)
Table Europe Biosimilar Sales by Application (2017-2022)
Table Europe Biosimilar Sales Share by Application (2017-2022)
Figure Asia-pacific Biosimilar Revenue and Growth Rate (2017-2022)
Table Asia-pacific Biosimilar Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Biosimilar Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilar Sales Market Share by Countries in 2021
Table Asia-pacific Biosimilar Revenue by Countries (2017-2022)
Table Asia-pacific Biosimilar Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Biosimilar Revenue Market Share by Countries in 2021
Figure China Biosimilar Sales and Growth Rate (2017-2022)
Figure South Korea Biosimilar Sales and Growth Rate (2017-2022)
Figure Japan Biosimilar Sales and Growth Rate (2017-2022)
Figure Australia Biosimilar Sales and Growth Rate (2017-2022)
Figure India Biosimilar Sales and Growth Rate (2017-2022)
Figure Southeast Asia Biosimilar Sales and Growth Rate (2017-2022)
Table Asia-pacific Biosimilar Revenue by Manufacturer (2021)
Figure Asia-pacific Biosimilar Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Biosimilar Sales by Type (2017-2022)
Table Asia-pacific Biosimilar Sales Share by Type (2017-2022)
Table Asia-pacific Biosimilar Sales by Application (2017-2022)
Table Asia-pacific Biosimilar Sales Share by Application (2017-2022)
Figure South America Biosimilar Revenue and Growth Rate (2017-2022)
Table South America Biosimilar Sales (Volume) by Countries (2017-2022)
Table South America Biosimilar Sales Market Share by Countries (2017-2022)
Figure South America Biosimilar Sales Market Share by Countries in 2019
Table South America Biosimilar Revenue by Countries (2017-2022)
Table South America Biosimilar Revenue Market Share by Countries (2017-2022)
Figure South America Biosimilar Revenue Market Share by Countries in 2019
Figure Brazil Biosimilar Sales and Growth Rate (2017-2022)
Table South America Biosimilar Sales by Type (2017-2022)
Table South America Biosimilar Sales Share by Type (2017-2022)
Table South America Biosimilar Revenue by Type (2017-2022)
Table South America Biosimilar Revenue Share by Type (2017-2022)
Table South America Biosimilar Sales by Application (2017-2022)
Table South America Biosimilar Sales Share by Application (2017-2022)
Figure Middle East and Africa Biosimilar Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilar Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Biosimilar Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilar Sales Market Share by Countries in 2019
Table Middle East and Africa Biosimilar Revenue by Countries (2017-2022)
Table Middle East and Africa Biosimilar Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Biosimilar Revenue Market Share by Countries in 2019
Figure GCC Countries Biosimilar Sales and Growth Rate (2017-2022)
Figure Turkey Biosimilar Sales and Growth Rate (2017-2022)
Figure Egypt Biosimilar Sales and Growth Rate (2017-2022)
Figure South Africa Biosimilar Sales and Growth Rate (2017-2022)
Table Middle East and Africa Biosimilar Sales by Type (2017-2022)
Table Middle East and Africa Biosimilar Sales Share by Type (2017-2022)
Table Middle East and Africa Biosimilar Revenue by Type (2017-2022)
Table Middle East and Africa Biosimilar Revenue Share by Type (2017-2022)
Table Middle East and Africa Biosimilar Sales by Application (2017-2022)
Table Middle East and Africa Biosimilar Sales Share by Application (2017-2022)
Table Global Biosimilar Sales by Type (2017-2022)
Table Global Biosimilar Sales Market Share by Type (2017-2022)
Figure Global Biosimilar Sales Market Share by Type in 2021
Table Global Biosimilar Revenue by Type (2017-2022)
Table Global Biosimilar Revenue Market Share by Type (2017-2022)
Figure Global Biosimilar Revenue Market Share by Type in 2019
Figure Global Monoclonal Antibodies Sales Growth Rate (2017-2022)
Figure Global Monoclonal Antibodies Price (2017-2022)
Figure Global Interferon Sales Growth Rate (2017-2022)
Figure Global Interferon Price (2017-2022)
Figure Global Erythropoietin Sales Growth Rate (2017-2022)
Figure Global Erythropoietin Price (2017-2022)
Figure Global Insulin Sales Growth Rate (2017-2022)
Figure Global Insulin Price (2017-2022)
Figure Global Vaccines Sales Growth Rate (2017-2022)
Figure Global Vaccines Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Other Price (2017-2022)
Table Global Biosimilar Sales by Application (2017-2022)
Table Global Biosimilar Sales Market Share by Application (2017-2022)
Figure Global Biosimilar Sales Market Share by Application in 2021
Figure Global Tumor Sales Growth Rate (2017-2022)
Figure Global Diabetes Sales Growth Rate (2017-2022)
Figure Global Cardiovascular Sales Growth Rate (2017-2022)
Figure Global Hemophilia Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Biosimilar Sales and Growth Rate (2022-2027)
Figure Global Biosimilar Revenue and Growth Rate (2022-2027)
Table Global Biosimilar Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Market Share Forecast by Regions (2017-2022)
Figure North America Sales Biosimilar Market Forecast (2022-2027)
Figure Europe Sales Biosimilar Market Forecast (2022-2027)
Figure Asia-Pacific Sales Biosimilar Market Forecast (2022-2027)
Figure South America Sales Biosimilar Market Forecast (2022-2027)
Figure Middle East & Africa Sales Biosimilar Market Forecast (2022-2027)
Table Global Biosimilar Sales Forecast by Type (2022-2027)
Table Global Biosimilar Market Share Forecast by Type (2022-2027)
Table Global Biosimilar Sales Forecast by Application (2022-2027)
Table Global Biosimilar Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Roche
Eli Lilly
Sanofi-Aventis
Amgen
Novo Nordisk
AbbVie
Merck
Pfizer
Johnson & Johnson
Novartis
Gelgen
Ganlee
3sbio
Innovent
Biotech
Changchun High Tech
Dong Bao
CP Guojian
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)